Omega Fund Management, LLC / BBOT
Omega Fund Management, LLC’s Bridgebio Oncology Therapeut Position
Does Omega Fund Management, LLC own Bridgebio Oncology Therapeut (BBOT)? Yes — 3.29M shares worth $29M (+18.05% of its 13F portfolio) as of Q1 2026.
Position Value
$29M
Q1 2026
Shares
3.29M
% of Portfolio
+18.05%
Quarters Held
3
currently held
Position History BBOT
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Omega Fund Management, LLC’s full portfolio or all institutional holders of BBOT.